Extramedullary plasmacytoma (EMP): Report of a case manifested as a mediastinal mass and multiple pulmonary nodules and review of literature
© Luh et al; licensee BioMed Central Ltd. 2007
Received: 29 July 2007
Accepted: 27 October 2007
Published: 27 October 2007
Extramedullary plasmacytoma (EMP) is a rare plasma cell neoplasm of soft tissue without bone marrow involvement or other systemic characteristics of multiple myeloma
A 42 year-old woman presented with intermittent dry cough of 10 months duration. Her breathing sound was slightly coarse without rales or rhonchi on auscultation. CT scan revealed a right anterior mediastinal shadow with multiple pulmonary nodular lesions. A video-assisted thoracoscopic surgery (VATS) was performed. Histopathology showed it to be a myeloma.
This is the first presentation of EMP with a mediastinal mass with multiple pulmonary nodules.
Extramedullary plasmacytoma (EMP) is a plasma cell neoplasm of soft tissue without bone marrow involvement or other systemic characteristics of multiple myeloma [1–3]. It is rare and mainly involves the upper aero-digestive tract. Herein we report an extremely unusual presentation as a mediastinal mass and multiple pulmonary nodules, but without bone marrow involvement or other characteristics of multiple myeloma.
Tracing back her history, she was a non-smoker, without occupational or environmental exposure to air pollutants or micro-organisms. No family members had any similar clinical manifestations nor had any died of cancer before. No related travel history was noted during this time.
After admission, a bronchoscopic examination revealed no endobronchial lesion or abnormal secretions. A pulmonary function test showed a mild restrictive ventilatory defect. The whole body bone scan was negative for tumor involvement. A CT-guided biopsy was recommended but the patient refused to undergo this procedure. The hemogram, leukocyte differentiation count, and coagulating profile were all within normal ranges.
After confirming the diagnosis, the patient received a series of related evaluations such as serum calcium, urine Bence-Jones protein and plasma electrophoresis for M protein detection. However, all of the above examinations were negative. The skull, spine and pelvis X-ray revealed no osteolytic lesions. The bone marrow biopsy revealed normal patterns of cell distribution.
She received adjuvant chemotherapy, as originally planned, including mephalan and steroids, and her symptoms improved after two months of treatment.
Plasma cell neoplasm can be classified into the following types: multiple myeloma (bone marrow and other systemic involvements), solitary myeloma (bone plasmacytoma), extramedullary (soft tissue) plasmacytoma, and plasmablastic sarcoma . Extramedullary plasmacytoma (EMP), which belongs to the category of non-Hodgkin's lymphoma, is present in about 3% of all plasma cell neoplasms [4–7]. It is defined as a soft-tissue plasma cell tumor occurring in the absence of systemic signs of multiple myeloma, such as bone osteolytic lesions, plasma cell infiltration in bone marrow, lytic bone lesion, or serum or urine myeloma protein (M-component) . EMP affects males three to four times more often than females, with an average age of 55. However, one third of patients with EMP are under 50 years old [1, 6, 8]. In a comprehensive literature search reviewing over 700 patients with EMPs, the EMPs were located predominantly (over 80%) at the upper aeordigestive tract. Pulmonary or pleural EMPs, which was first reported by Gordon and Walker , only occurred in twelve of them . Their presentations varied, from a single pulmonary nodule (most commonly in the hilum, the upper lobe of the lung, and both sides of the lungs equally affected), a lobar or segmental consolidation, to bilateral diffuse infiltrates [2, 10–14]. However, none of them had clinical pictures or image findings similar to our presented case (a mediastinal mass with bilateral multiple pulmonary nodules).
Diagnosis of undetermined pulmonary nodular lesions can be accomplished by transbronchial, CT- or sono- guide needle biopsy, as well as surgical biopsy through the VATS or open thoracotomy [15, 16]. VATS has been increasingly applied for the diagnosis or treatment of undetermined solitary or multiple pulmonary nodule(s) because it is more accurate in diagnosis than needle biopsy and less invasive in treatment than the open procedure .
The EMP should be differentiated from other plasma cell tumors. As described in the above paragraph, there should be no systemic signs to exclude the possibility of multiple myeloma. In addition, the EMP should also be differentiated from other types of plasma cell tumor, such as reactive plasmacytoma and plasma cell granuloma, or lymphoma (MALT, marginal and immunoblastic) [7, 18]. Although the absence of M-spike on plasma electrophresis cannot differentiate EMP from benign granuloma, , the clinical characteristics such as the size of the main mass and the numerous pulmonary seeding nodular lesions favor the diagnosis of malignant EMP. The best method to differentiate EMP from other types of plasma cell tumors or lymphomas is that the EMP is positive for CD38 and monoclonal cytoplasmic light chain expression of malignant plasma cells obtained by surgical or needle biopsy.
Like other plasma cell tumors, EMPs are highly radiosensitive with 80 to 100% of patients successfully achieving local control and with a 50 to 65% ten-year disease-free survival rate [19, 20]. Surgery can be considered for localized EMPs located in areas other than the head and neck, such as the gastrointestinal tract . Localized EMPs can also be effectively controlled by irradiation . Multiple disseminated pulmonary plasmacytoma, such as in our presented patient, can be effectively controlled by different regimens of combined chemotherapeutic agents, such as mephalan and steroids, VMCP or VAMP, as described in other literature [22–24]. The prognosis of patients with EMP is usually better than those with multiple myeloma. The EMPs, unlike solitary myeloma, advances to multiple myeloma only in a minority of cases . The local recurrence rate is about 10–30%, with a 17–48% progression to multiple myeloma and the median survival of about 63–101 months .
We presented a case of EMP with a mediastinal mass with multiple pulmonary nodules. After reviewing the literature, this has never before been reported as a clinical manifestation of EMP.
Written consent was obtained from the patient for publication of this case report. The authors would like to thank Lai-Ching Wong and Po-Chi Huang of the Department of Pathology, Taichung Hospital for their work on special staining in the resected specimen.
- Galieni P, Cavo M, Pulsoni A, Avvisati G, Bigazzi C, Neri S, Callceti U, Benni M, Ronconi S, Lauria F: Clinical outcome of extramedullary plasmacytoma. Hematologica. 2000, 85: 47-51.Google Scholar
- Alexiou C, Kau RJ, Dietztelbinger H, Kremer M, Spiess JC, Schratzenstaller B, Amold W: Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999, 85: 2305-2314. 10.1002/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3.View ArticlePubMedGoogle Scholar
- Dimopoulos MA, Kiamouris C, Moulopoulos LA: Solitary plasmacytoma of bone and extramedullary plasmacytoma. Hematol Oncol Clin North Am. 1999, 13: 1249-1257. 10.1016/S0889-8588(05)70124-6.View ArticlePubMedGoogle Scholar
- Fanning SR, Hussain MA, Perez-Zincer F: Plasmacytoma, extramedullary. Emedicine. 2006, [last accessed on October 19, 2007], http://www.emedicine.com/med/topic2532.htmGoogle Scholar
- Barti R, Frisch B, Fateh-Moghadam A, Kettner G, Iaeger K, Sommerfeld W: Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol. 1987, 87: 342-355.Google Scholar
- Knowling MA, Harwood AR, Bergsagel DE: Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol. 1983, 1: 255-262.PubMedGoogle Scholar
- Dimopoulos MA, Hamilos G: Solitary bone plasmacytoma and extramedullary plasmacytoma. Curr Treat Options Oncol. 2002, 3: 255-259. 10.1007/s11864-002-0015-2.View ArticlePubMedGoogle Scholar
- Holland J, Trenkner DA, Wasseman TH, Tinberg B: Plasmacytoma. Treatment results, and conversion to myeloma. Cancer. 1992, 69: 1513-1517. 10.1002/1097-0142(19920315)69:6<1513::AID-CNCR2820690633>3.0.CO;2-X.View ArticlePubMedGoogle Scholar
- Gordon J, Walker G: Plasmacytoma of the lung. Arch Pathol. 1944, 37: 222-224.Google Scholar
- Amin R: Extramedullary plasmacytoma of the lung. Cancer. 1985, 56: 152-156. 10.1002/1097-0142(19850701)56:1<152::AID-CNCR2820560124>3.0.CO;2-E.View ArticlePubMedGoogle Scholar
- Kaneko Y, Satoh H, Haraguchi N, Imagawa S, Sekizawa K: Radiologic findings in primary pulmonary plasmacytoma. J Thorac Imaging. 2005, 20: 53-54. 10.1097/01.rti.0000139389.88019.63.View ArticlePubMedGoogle Scholar
- Joseph G, Pandit M, Korfhage L: Primary pulmonary plasmacytoma. Cancer. 1993, 71: 721-724. 10.1002/1097-0142(19930201)71:3<721::AID-CNCR2820710311>3.0.CO;2-U.View ArticlePubMedGoogle Scholar
- Egashira K, Hirakata K, Nakata H, Kawanami S, Mitsudomi T, Nakano S, Ohno M: CT and MRI manifestations of primary pulmonary plasmacytoma. Clin Imaging. 1995, 19: 17-19. 10.1016/0899-7071(94)00033-9.View ArticlePubMedGoogle Scholar
- Wise JN, Schaefer RF, Read RC: Primary pulmonary plasmacytoma. A case report. Chest. 2001, 120: 1405-1407. 10.1378/chest.120.4.1405.View ArticlePubMedGoogle Scholar
- Miller DL: Management of the subcentimeter pulmonary nodule. Semin Thoracic Cardiovasc Surg. 2002, 14: 281-285.View ArticleGoogle Scholar
- Whyte RI: Advances in the staging of intrathoracic malignancies. World J Surg. 2001, 25: 167-173. 10.1007/s002680020015.View ArticlePubMedGoogle Scholar
- Luh SP, Liu HP: Video-assisted thoracic surgery. The past, present status and the future. J Zhejiang Univ Sci. 2006, 7: 118-128. 10.1631/jzus.2006.B0118.View ArticleGoogle Scholar
- Guidelines Working Group of the UK Myeloma Forum (UKMF): Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Hematol. 2004, 124: 717-726. 10.1111/j.1365-2141.2004.04834.x.View ArticleGoogle Scholar
- Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, Stewart AK: Solitary plasmacytoma treated with radiotherapy: Impact of tumor size on outcome. Int J Radiat Oncol Biol Phys. 2001, 50: 113-120. 10.1016/S0360-3016(00)01572-8.View ArticlePubMedGoogle Scholar
- Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R: Clinical course of extramedullary plasmacytoma. Radiother Oncol. 1999, 52: 245-249. 10.1016/S0167-8140(99)00114-0.View ArticlePubMedGoogle Scholar
- Weber DM: Solitary bone and extramedullary plasmacytoma. Hematology Am Soc Hematol Educ Program. 2005, 373-376.Google Scholar
- Nitsu N, Kohri M, Hayama M, Nakamine H, Nakamura N, Bessho M, Higashihara M: Primary pulmonary plasmacytoma involving bilateral lungs and hypergammaglobinemia. Differentiation from extranodal marginal lymphoma of mucosa associated lymphoid tissue. Leuk Res. 2005, 29: 1361-1364. 10.1016/j.leukres.2005.04.009.View ArticleGoogle Scholar
- Lazarevic V, Cemerikic-Martinovic V, Suvajdzic N, Subotic D, Colovic M: Diffuse primary plasmacytoma of the lung. Haematologica. 2001, 31: 161-165. 10.1163/15685590152492972.View ArticleGoogle Scholar
- Wang J, Pandha HS, Treleaven J, Poweles R: Metastatic extramedullary plasmacytoma of the lung. Leuk Lymphoma. 1999, 35: 423-425.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.